Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Sarb99on Apr 17, 2021 1:16am
487 Views
Post# 33016375

Hidden I did some research, and the results are below

Hidden I did some research, and the results are below

I have nothing against you as stock prices went down and many people got frustrated. That is what the stock market is. If the penny stocks are guaranteed to succeed then people will invest every single penny they own into penny stocks.

 

Here is what I think about installing 2000 cubes. As we all know covid numbers were high in November, December and January. It seems management got excited and started talking big. Then February came and testing numbers tumble all over the USA not only at collection sites. The logic is if you can't fill existing testing sites. Then what is the point to install more cubes and pay rent for nothing. Questing at that point should be how to move forward and increase the revenue in other ways.

 

Medivolve management did not sit on their hands. They started adding more options for testing like immune score and selling home-based testing kits. Collection sites starting to offer Govt-funded covid testing to uninsured and undocumented people. They are working on a vaccine contract. 

 

We knew all the time by checking the website as to how many collection sites are installed. 

 

About 160 tests per cube, all they said was these cubes can perform up to 160 tests per day. I don't see anywhere they said they will for sure be doing 160 tests every day. As to how many tests they do it, depends on how many clients they get. 

 

Also another tip: You talk about all the write-offs, all those deals were signed by Scott Moore QuestCap CEO at that time. Click on the news on the StockHouse and look at all those deals signed on pages 4-5-6. Doug Sommerville became QuestCap CEO on April 29th, and all those deals were signed before that. https://stockhouse.com/news/press-releases/2020/04/29/questcap-appoints-new-ceo-and-executive-chairman-and-closes-financing-for

 

The way I see it, Doug Sommerville had to clean up all that mess. If you research Doug did not pay much of the remaining balance. A couple of times they moved the date to pay that money. If all of these companies did not show any result then why throw more money at them. So Doug cancelled all these deals. Most of those shares were paid by Scott Moore. Doug brought collection sites, The Sanaty IPS, Glenco Medical and Nuturell. 

 

You talk about the Karland Health deal and here are a few things to consider:

 

First here are the people "Blackport Hodgers Partners Inc" who were selling the Karland deal https://esos.nv.gov/EntitySearch/BusinessInformation and are the same people whos assigned QuestCap Lyher Covid testing kits in July 2020 

 

QuestCap Inc. has become the exclusive authorized sales agent in the United States, Canada, and Mexico for Hangzhou Laihe Biotech. Blackport Holdger Partners Inc. assigned QuestCap the right to act as an official exclusive agent through their role as the exclusive authorized North America representative of Hangzhou Laihe LYHER tests. https://stockhouse.com/news/press-releases/2020/07/30/questcap-secures-exclusive-sales-rights-for-emergency-use-authorized-covid-19

If you go look at my posts in July 2020 I posted a link to this company https://chemvest.com/team/ If you do a little research you will find they work kind of middle man. They do not manufacture Covid-19 testing kits. All they did was applied and got FDA approval in the USA for Layher testing kits. Then assigned those rights to QuestCap probably per test kit profit. If they were the middle man in this deal then creating newco makes sense. So it is possible they brought another deal to Doug and made him excited. Once the company did their due diligence it did not match up. 

 

As you kept posting your frustration, I decided to do some research and all are above. This is only my opinion but you use these links to your research. 

 

Yes, a few things Doug probably has done differently but every human mak mistakes. 

 

<< Previous
Bullboard Posts
Next >>